Figure 4 from Bcl-xL Is a Key Mediator of Apoptosis Following KRAS<sup>G12C</sup> Inhibition in <i>KRAS<sup>G12C</sup></i>-mutant Colorectal Cancer

Figure 4 from Bcl-xL Is a Key Mediator of Apoptosis Following KRAS<sup>G12C</sup> Inhibition in <i>KRAS<sup>G12C</sup></i>-mutant Colorectal Cancer

<p>High-throughput drug screen reveals that pharmacologic inhibition of Bcl-xL synergizes with KRAS<sup>G12C</sup> inhibition in <i>KRAS</i><sup>G12C</sup> MT colorectal cancer. <b>A,</b> SW837 and SNU1411 cells were cotreated with 1 μmol/L AZ’15...

Volledige beschrijving

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Hajrah Khawaja (15090810) (author)
Andere auteurs:	Rebecca Briggs (15090813) (author), Cheryl H. Latimer (15090816) (author), Mustasin Rassel (15090819) (author), Daryl Griffin (15090822) (author), Lyndsey Hanson (15090825) (author), Alberto Bardelli (15046646) (author), Frederica Di Nicolantonio (15090828) (author), Simon S. McDade (14939679) (author), Christopher J. Scott (15090831) (author), Shauna Lambe (15090834) (author), Manisha Maurya (15090837) (author), Andreas U. Lindner (15033719) (author), Jochen H.M. Prehn (15033731) (author), Jose Sousa (15090840) (author), Chris Winnington (15090843) (author), Melissa J. LaBonte (15090846) (author), Sarah Ross (15090849) (author), Sandra Van Schaeybroeck (15090852) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Cancer Biology Therapeutic Research and Development Drug Resistance Novel mechanisms Gastrointestinal Cancers Colorectal cancer Oncogenes & Tumor Suppressors Kras
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!